Indefinite Delivery Contract SPE2DR25D9759

The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. This IDC, under the SPE2DR program, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

The original solicitation indicates that DLA plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support to various DoD customers. The contracts will have a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. Awards will be made on a regional basis to at least three different contractors across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet regions, with both primary and backup suppliers providing separate distribution fees for brand/generic and specialty pharmaceuticals to support normal and contingency operations globally.